Abstract
Classic Kaposi sarcoma (KS) usually is a localized and slowly progressing disease that mainly affects elderly patients; therefore, local treatment generally is recommended. In this study, we evaluated the clinical efficacy of intralesional vinblastine (VNB) for the treatment of classic KS in 6 participants with type 2 diabetes mellitus. Results indicated that intralesional VNB injections may be an effective alternative treatment of classic KS in diabetic patients.
Original language | English |
---|---|
Pages (from-to) | E28-E34 |
Journal | Cutis |
Volume | 95 |
Issue number | 5 |
Publication status | Published - 2015 |
ASJC Scopus subject areas
- Dermatology